Topical Analgesics;Analgésicos Tópicos

Revista Brasileira de Anestesiologia

Volumn 62, Issue 2, 2012, Pages 244-252

  Flores, Murilo Pereira ^a   de Castro, Anita Perpetua Carvalho Rocha ^b   Nascimento, Jedson dos Santos ^c  

^a ME3 Anesthesiology Program CET SBA Santa Casa de Misericórdia da Bahia SCMB   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c SCMB ^*  (Brazil)

Author keywords

Administration, Topical; Analgesia; Analgesics, Opioid; Anesthetics, Local; Anti inflammatory Agents; Antidepressive Agents, Tricyclic; Cannabinoids; Capsaicin; Ketamine

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CANNABINOID; CAPSAICIN; CLONIDINE; DIAMORPHINE; DOXEPIN; EMLA; KETAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENERGIC ACTIVITY; ANALGESIC ACTIVITY; ANTINOCICEPTION; APPLICATION SITE BURNING; APPLICATION SITE ERYTHEMA; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HALLUCINATION; HUMAN; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NONHUMAN; PAIN; POSTHERPETIC NEURALGIA; RESPIRATION DEPRESSION; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ANALGESICS; HUMANS; PAIN;

EID: 84858597725     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1016/S0034-7094(12)70122-8     Document Type: Article

References (30)

1. McCleane G. Topical analgesics. Anesthesiol Clin 2007, 25:825-839.
2. Haroutiunian S., Drennan D.A., Lipman A.G. Topical NSAID therapy for musculoeskeletal pain. Pain Medi 2010, 11:535-549.
3. de Leon-Casasola O.A. Multimodal approaches to the management of neuropathic pain: the role of topical analgesia. J Pain Symptom Manage 2007, 33(3):356-364.
4. Heyneman C.A., Lawless-Liday C., Wall G.C. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 2000, 60:555-574.
5. Roelofs P.D., Deyo R.A., Koes B.W., Scholten R.J., van Tulder M.W. Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review. Spine 2008, 33(16):1766-1774.
6. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118(3):289-305.
7. Lai J., Porreca F., Hunter J.C., Gold M.S. Voltage-gated sodium channel and hyperalgesia. Annu Rev Pharmacol Toxicol 2004, 44:371-397.
8. Gammaitoni A.R., Alvarez N.A., Galer B.S. Pharmacokinetics and safety of continuously applied lidocaine patches 5%. Am J Health Syst Pharm 2000, 59(22):2215-2220.
9. Katz N.P., Gammaitoni A.R., Davis M.W., Dworkin R.H. Lidocaine patch 5% reduces pain intensity and interference with quality of life in pacients with postherpetic neuralgia: an effectiveness trial. Pain Med 2002, 3(4):324-332. Lidoderm Patch Study Group.
10. Barbano R.L., Herrmann D.N., Hart-Gouleau S., Pennella-Vaughan J., Lodewick P.A., Dworkin R.H. Effectiveness, tolerability, and impact in quality of life of he %5 lidocaine patch in diabetic polineuropathy. Arch Neurol 2004, 61(6):914-918.
11. Meier T., Wasner G., Faust M. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003, 106:151-158.
12. Attal N., Brasseur L., Chauvin M., Bouhassira D. Effects of single and repeated applications of a eutectic mixture of local anaesthetics (EMLA) cream on spontaneous and evoked pain in post-herpetic neuralgia. Pain 1999, 81:203-209.
13. Mason L. Systematic review of topical capsaicin for the treatment of chronic Pain. British Journal of Medicine 2004, 7446:328-991.
14. Nolano M., Simone D.A., Wendelschafer-Crabb G., Johnson r.T., Hazen E., Kennedy W.R. Topical capsaicin in humans: parallel loss of epidermal nerve fibres and pain sensation. Pain 1999, 81:135-145.
15. Simone D.A., Nolano M., Johnson T., Wendelschafer-Crabb G., Kennedy W.R. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibres: correlation with sensory function. J Neurosci 1998, 18:8947-8959.
16. Dogrul A. Topical clonidine antinociception. Pain 2004, 111:385-391.
17. Byas-Smith M.G. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain 1995, 60(3):267-274.
18. Ho K., Huh B.K., White W.D., Yeh C.C., Miller E.J. Topical Amitriptyline Versus Lidocaine in the Treatment of Neuropathic Pain. Clin J Pain 2008, 24:51-55.
19. Lockhart E. Topical combination of amitriptyline and ketamine for post herpetic neuralgia. J Pain 2004, 5(s1):82.
20. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000, 49:574-579.
21. Epstein J.B., Epstein J.D., Epstein M.S., Oien H., Truelove E.L. Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncol 2001, 37:632-637.
22. Gammaitoni A. Topical ketamine gel: possible role in treating neuropathic pain. Pain Med 2000, 1(1):97-100.
23. Crowley K.L., Flores J.A., Hughes C.N., Iacono R.P. Clinical application of ketamine ointment in the treatment of significant allodynia and hyperalgesia associated with chronic neuropathic pain. J Pharm Comp 1998, 2:123-127.
24. Finch P.M. Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine. Pain 2009, 146:18-25.
25. Flock P., Gibbs L., Sykes N. Diamorphine metronidazole gel effective for treatment of painful infected leg ulcers. J Pain Symptom Manage 2000, 20:396-397.
26. Zeppetella G., Paul J., Ribeiro M.D.C. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 2003, 25:555-558.
27. Zeppetella G., Ribeiro M.D. Morphine in intra-site gel applied topically to painful ulcers 2005, 29:118-119.
28. Cerchietti L.C.A., Navigante A.r.H., Bonomi M.R. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002, 95:2230-2236.
29. Dogrul A. Topical cannabinoid antinociception. Pain 2003, 105:11-16.
30. Yesilyurt O. Topical cannabiboid enhances topical morphine antinociception. Pain 2003, 105:303-308.